OVERVIEW

2021 UVA 16th Annual Conference of Liver Disease and Gastroenterology is organized by University of Virginia (UVA) and will be held on Apr 24, 2021.

CME Accreditation:
The University of Virginia School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Description:
The 16th Uva Annual Conference of Liver Disease & Gastroenterology Course Is Designed to Provide General and Community Based Gastroenterology Physicians, Physician Assistants, and Nurse Practitioners an Opportunity to Learn About and Discuss the Advances in the Diagnosis and Treatment of Patients With Liver Disease and Luminal Gi Diseases. Due to the Covid-19 Pandemic, We Will Be Virtual This Year. Lectures Will Cover Topics in Celiac Disease, Eosinophilic Esophagitis, Wellness Strategies for Liver Disease and for Functional Bowel Disease Patients, Uses for Sacral Nerve Modulation in Gi Disease, Crohn’s Disease, Recovery Strategies With Different Endoscopic Sedation, Tips and Pearls for Endoscopic Mucosal Resection, Ercp Strategies in Gastric Bypass Patients, Hepatocellular Carcinoma and Non-invasive Fibrosis Measurements in Viral Hepatitis. During Our Poster Symposium, We Will Feature Research and Quality Improvement Projects Presented by Trainees.

Educational Objectives:
At the Completion of This Program, Participants Will Be Able to:
• Discuss the Management of Celiac Disease and New Therapies
• Determine the Role of Food Allergens in Eosinophilic Esophagitis
• Formulate a Plan for Using Wellness Strategies in the Treatment of Liver Disease and Functional Bowel Disease Patients
• Describe the Role of Sacral Nerve Modulation in the Treatment of Fecal Incontinence
• Differentiate the Current and Future Therapies for Crohn’s Disease
• Develop Strategies to Recover Patients Who Have Received Moderate Sedation or Propofol in Endoscopy
• Summarize the Techniques and Methods for Endoscopic Mucosal Resection
• Develop Strategies for the Use of Ercp in Patients With Previous Gastric Bypass Surgery
• Review the Diagnosis and New Therapies for Hepatocellular Carcinoma
• Determine the Role of Non-invasive Markers and Testing to Assess Fibrosis in Patients With Viral Hepatitis